Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Aurora Cannabis Inc (ACB) is a leading drug manufacturers-specialty & generic business based in the US. It opened the day at $1.33 after a previous close of $1.32. During the day the price has varied from a low of $1.30 to a high of $1.38. The latest price was $1.35 (25 minute delay). Aurora Cannabis is listed on the NASDAQ and employs 1,761 staff. All prices are listed in US Dollars.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Open | $1.33 |
|---|---|
| High | $1.38 |
| Low | $1.30 |
| Close | $1.35 |
| Previous close | $1.32 |
| Change | $0.03 |
| Change % | 2.2727% |
| Volume | 4,648,702 |
| 52-week range | $1.21 - $8.86 |
|---|---|
| 50-day moving average | $2.19 |
| 200-day moving average | $4.60 |
| Wall St. target price | $5.12 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-4.70 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.35 from 2022-07-01
| 1 week (2022-06-27) | -12.90% |
|---|---|
| 1 month (2022-06-03) | -15.63% |
| 3 months (2022-04-01) | -65.82% |
| 6 months (2022-01-04) | -76.60% |
| 1 year (2021-07-02) | -84.34% |
|---|---|
| 2 years (2020-07-02) | -89.00% |
| 3 years (2019-07-03) | 7.68 |
| 5 years (2017-07-03) | 1.6909 |
| Revenue TTM | $225.9 million |
|---|---|
| Gross profit TTM | $-21,558,000 |
| Return on assets TTM | -6.25% |
| Return on equity TTM | -75.46% |
| Profit margin | 0% |
| Book value | $4.86 |
| Market capitalisation | $402 million |
TTM: trailing 12 months
We're not expecting Aurora Cannabis to pay a dividend over the next 12 months.
Aurora Cannabis's shares were split on a 1:12 basis on 10 May 2020. So if you had owned 12 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aurora Cannabis shares – just the quantity. However, indirectly, the new 1100% higher share price could have impacted the market appetite for Aurora Cannabis shares which in turn could have impacted Aurora Cannabis's share price.
Over the last 12 months, Aurora Cannabis's shares have ranged in value from as little as $1.21 up to $8.86. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aurora Cannabis's is 3.1307. This would suggest that Aurora Cannabis's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
